Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Alloimmunity and Transplantation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1479472
This article is part of the Research Topic Enhancing Immune Surveillance and Mitigating Alloreactivity in Transplantation: Approaches in Hematopoietic Stem Cell and Solid Organ Transplants View all 3 articles

Epstein-Barr virus-specific T-cell response in pediatric liver transplant recipients: a cross-sectional study by multiparametric flow cytometry

Provisionally accepted
Ricardo Cuesta-Martín De La Cámara Ricardo Cuesta-Martín De La Cámara 1,2,3*Andrea Torices-Pajares Andrea Torices-Pajares 2Laura Miguel-Berenguel Laura Miguel-Berenguel 1Keren Reche-Yebra Keren Reche-Yebra 2Esteban Frauca-Remacha Esteban Frauca-Remacha 4,5,6Loreto Hierro Loreto Hierro 4,5,6Gema Muñoz-Bartolo Gema Muñoz-Bartolo 4,5,6María Dolores Lledín-Barbacho María Dolores Lledín-Barbacho 4,5,6Almudena Gutiérrez-Arroyo Almudena Gutiérrez-Arroyo 7Ana Martínez-Feito Ana Martínez-Feito 1Eduardo Lopez-Granados Eduardo Lopez-Granados 1,2,6,8Elena Sánchez-Zapardiel Elena Sánchez-Zapardiel 1,2,6
  • 1 Clinical Immunology Department, University Hospital La Paz, Madrid, Spain
  • 2 University Hospital La Paz Research Institute (IdiPAZ), Madrid, Madrid, Spain
  • 3 Autonomous University of Madrid, Madrid, Madrid, Spain
  • 4 Paediatric Hepatology Department, University Hospital La Paz, Madrid, Spain
  • 5 European Reference Network (ERN), RARE LIVER, Madrid, Spain
  • 6 European Reference Network (ERN), TransplantChild, Madrid, Spain
  • 7 Microbiology Department, University Hospital La Paz, Madrid, Spain
  • 8 CIBERER U767, Centre for Biomedical Network Research on rare diseases, Madrid, Spain

The final, formatted version of the article will be published soon.

    Background. Epstein-Barr virus (EBV) specific T-cell response measurement can help adjust immunosuppression in transplant patients with persistent infections. We aim to define T-cell responses against EBV in a cohort of pediatric liver-transplant patients. Methods. Thirty-eight immunosuppressed pediatric liver-transplant patients (IP) and 25 EBV-seropositive healthy-adult controls (HC) were included in our cross-sectional study. Based on their EBV serological (S) and viral load (VL) status, patients were categorized into IP-SNEG, IP-SPOSVLNEG and IP-SPOSVLPOS groups. T-cell response was assessed at two timepoints by stimulating cells with EBV peptides (PepTivator®) and performing intracellular-cytokine and activation-induced marker staining. Background subtraction was used to determine EBV-specific T-lymphocyte frequency. Results. Polyfunctional CD8+ T cells indicated previous EBV contact (IP-SNEG 0.00% vs IP-SPOS 0.04% and HC 0.02%; p=0.001 and p=0.01, respectively). Polyfunctional CD8+CD107a+IFNɣ+IL2-TNFα- profile was increased in serology-positive (IP-SNEG 0.01% vs IP-SPOS 0.13% and HC 0.03%; p=0.01 and p=0.50, respectively) and viral-load positive (IP-SPOSVLPOS 0.43% vs IP-SPOSVLNEG 0.07% and HC 0.03%; p=0.03 and p=0.001, respectively) patients. Central-memory cells were increased among serology-positive adults (IP-SNEG 0.00% vs IP-SPOS 0.13% and HC 4.33%; p=0.58 and p=0.002, respectively). At the second timepoint, IP-SNEG patients remained negative (first visit 0.01% vs second visit 0.00%, p=0.44). On the other hand, IP-SPOSVLPOS patients had cleared viral loads and, subsequently, decreased polyfunctional CD8+CD107a+IFNɣ+IL2-TNFα- cells (first visit 0.43% vs second visit 0.10%, p=0.81). Conclusion. Polyfunctional CD8+ EBV-specific T-cell response allows detecting EBV previous contact in liver-transplant children. %CD8+CD107a+IFNɣ+IL2-TNFα- is increased in patients with positive viral loads. Central memory CD4+ T-cell population more effectively determines prior EBV-exposure in adults.

    Keywords: Liver Transplantation, Epstein-Barr Virus Infections, Cellular immunity, Flow Cytometry, Cytokines, Surface antigens

    Received: 12 Aug 2024; Accepted: 07 Oct 2024.

    Copyright: © 2024 Cuesta-Martín De La Cámara, Torices-Pajares, Miguel-Berenguel, Reche-Yebra, Frauca-Remacha, Hierro, Muñoz-Bartolo, Lledín-Barbacho, Gutiérrez-Arroyo, Martínez-Feito, Lopez-Granados and Sánchez-Zapardiel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ricardo Cuesta-Martín De La Cámara, Clinical Immunology Department, University Hospital La Paz, Madrid, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.